Whalesbook
Stock Aisa Bhaga Ke Record Bana Diya!
Marico ka share price ₹799.8 ke aas-paas pahunch gaya, ekdum record bana diya! Yeh stock sirf February mein hi 10% bhaga hai, jo Nifty FMCG ke 3.5% aur Nifty50 ke 3% se kaafi zyada hai. Q3 FY26 ke results ekdum zabardast aaye, overall revenue 27% badh kar ₹3,527 crore ho gaya. India business ne sabse zyada kamaal kiya, revenue 24% badha aur ₹2,461 crore tak pahunch gaya. Yeh lagatar teesra quarter hai jab India business 20% se zyada grow kar raha hai. Company ne Parachute hair oil pe 51% tak price increase kiya, jisse revenue aur badha. India mein volume growth bhi 8% se accha raha.
Premium Products & Naye Ventures Ka Kamaal
Company ne premium products pe kaafi focus kiya hai. Value-Added Hair Oil (VAHO) segment mein 20% tak ka growth dikha hai. Matlab, high-margin products achhe se bik rahe hain. Aur yehhi wajah hai ki HSBC jaise analysts ko lagta hai ki is stock ko premium valuation milna chahiye. Marico apna Foods aur Digital-First (D2C) business bhi badha rahi hai, jo ab sales ka 22% ho gaya hai. 4700BC jaise gourmet snacking brands aur Cosmix jaise nutrition platforms ko acquire karna bhi isi strategy ka hissa hai. International business jo FY25 revenue ka 25% hai, woh bhi accha perform kar raha hai.
Analysts Kya Keh Rahe Hain?
Abhi Marico ka share Price-to-Earnings (P/E) ratio lagbhag 57-60x chal raha hai, jo Dabur India (49-50x) aur Bajaj Consumer Care (28-31x) jaise competitors se zyada hai. Waise, Nifty FMCG sector khud zyada move nahi kar raha hai. HSBC ne 'Buy' rating aur ₹900 ka target maintain kiya hai, woh core categories ki strength aur operating leverage dekh rahe hain. Jefferies ne bhi 'Buy' rating aur ₹900 ka target diya hai, diversification strategy ko saraha hai. Stock ka beta coefficient sirf 0.49 hai, matlab yeh market ke hisaab se kam volatile hai, ek tarah ka defensive stock hai. Management ka kehna hai ki EBITDA growth mid-teens mein aur margin 150-200 basis points tak badh sakta hai, input costs kam hone ki wajah se.
⚠️ Par Copra Ka Risk Mat Bhoolo!
Par bhaiyo, sab kuch itna bhi sunhera nahi hai. BNP Paribas wale analysts thoda cautious hain aur 'Neutral' rating ke saath ₹835 ka target de rahe hain. Inka main point hai Copra ka downcycle. History mein jab Copra ke prices girte hain, toh Marico ki growth aur margins par pressure aata hai. Company coconut oil derivatives pe kaafi depend karti hai. Premiumization aur diversification achhi hai, par company ka bada oil business hai, toh commodity prices ka risk abhi bhi hai. Saffola edible oils mein volume growth sustain na karna aur international markets mein issues bhi potential risks hain. Jo current high P/E multiple hai, woh market ki badi expectations dikhata hai, agar performance mein thodi bhi gadbad hui toh stock gir sakta hai.
Aage Kya Ho Sakta Hai?
Aage kya? Marico ka management apne naye acquire kiye huye aur D2C businesses ko aur bada karne pe focus kar raha hai, jisse FY30 tak revenue ka bada share unse aaye. HSBC ko lagta hai ki digital-first premium personal care segments ke EBITDA margins FY27 tak double digits mein aa jayenge. Core oil business stability dega, par long-term growth ke liye naye ventures ka success bahut important hai. Company ka target hai ki 2030 tak Rs 20,000 crore ka revenue kamaaye. Overall, analysts ka consensus positive hai, average target price ₹850-867 ke aas-paas hai, agar company near-term commodity cycle headwinds ko manage kar paati hai toh.